Abstract
The spectrum of HIV-associated neurocognitive disorder (HAND) has been dramatically altered in the setting of widely available effective antiretroviral therapy (ART). Once culminating in dementia in many individuals infected with HIV, HAND now typically manifests as more subtle, though still morbid, forms of cognitive impairment in persons surviving long-term with treated HIV infection. Despite the substantial improvement in severity of this disorder, the fact that neurologic injury persists despite ART remains a challenge to the community of patients, providers and investigators aiming to optimize quality of life for those living with HIV. Cognitive dysfunction in treated HIV may reflect early irreversible CNS injury accrued before ART is typically initiated, ongoing low-level CNS infection and progressive injury in the setting of ART, or comborbidities including effects of treatment which may confound the beneficial reduction in viral replication and immune activation effected by ART. © 2013 The Author(s).
Author supplied keywords
- Acute HIV infection
- Antiretroviral therapy
- Blood-brain barrier
- CNS reservoir
- Central nervous system
- Central nervous system penetration effectiveness
- Cerebrospinal fluid
- Compartmentalization
- Efavirenz
- HIV escape
- HIV reservoir
- HIV-associated dementia
- HIV-associated neurocognitive disorder
- HIV/AIDS
- Microglia
- Monocyte efficacy
- Neurotoxicity
- Primary HIV infection
- Viral load
Cite
CITATION STYLE
Spudich, S. (2013). HIV and neurocognitive dysfunction. Current HIV/AIDS Reports, 10(3), 235–243. https://doi.org/10.1007/s11904-013-0171-y
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.